Taipei, June 13 (CNA) Taiwanese entertainer Jia Yong-jie (賈永婕) said Sunday that she has raised enough money to buy 330 high-flow nasal cannula (HFNC) machines, an oxygen supply system used in hospitals, adding that distribution of the devices started the previous day.
Limited testing, elderly patients and overflowing hospitals could be responsible for Taiwan’s higher than average COVID-19 case-to-fatality ratio, National Taiwan University Hospital doctor Lee Chien-chang (李建璋) said on Wednesday.
The number of COVID-19 deaths in Taiwan has risen to 411, including 399 since May 15, Central Epidemic Command Center data released yesterday showed.
The nation’s death rate from COVID-19 among confirmed cases is higher than the 2.14 percent global average.
Lee, a Harvard University-trained epidemiologist and doctor of emergency medicine, said that the rate in Taiwan is likely to climb to about 3 percent.
Mortality rates among confirmed cases are dependent on testing capacity.
Medigen vaccine data good but questions remain: Experts
06/11/2021 05:34 PM
CNA file photo
Taipei, June 11 (CNA) The Phase 2 clinical trial results of a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. generated good data, experts have said, but they cautioned there was still no way to know how effectively it will protect people against getting the disease. Data looks quite good, Academia Sinica academician Michael M.C. Lai (賴明詔), a reputed virologist and coronavirus researcher, told CNA on Thursday after Medigen announced that its vaccine candidate had shown no major safety concerns.
Lai said the published data showed the vaccine was able to produce sufficient neutralizing antibodies, and as long as there were antibodies, there should be protection, while also noting that its toxicity was low.
Phase 2 clinical trial results of a COVID-19 vaccine developed by Medigen Vaccine Biologics Corp generated good data, experts said, although they warned that there was still no way to know how effectively it would prevent the disease.
“Data look quite good,” Academia Sinica researcher Michael Lai (賴明詔) said on Thursday after Medigen announced that its vaccine candidate had shown no major safety concerns.
The data showed that the vaccine produced sufficient neutralizing antibodies and as long as there were antibodies, there should be protection, Lai said, adding that its toxicity was low.
The Medigen vaccine has achieved the goals of creating sufficient